BAX-Gammagard
Dew, my recall is that for 6 month studies, Aricept maintained less than 2 pt decline vs. 5 point decline for control patients. Given the Gammagard study is 18 months, it would translate into a 3-5 point decline for study patients and 15 point decline for control, patients. I've posted many times, a couple of ADAS points saved do not a good drug make.
Of course, the original Aricept data is now getting a little long in the tooth and as it fades into historical memory stores, all kinds of distortions might be acting on it. No worries about my memory, I'll choose a path of decline that is markedly different than the typical DAT patient if I become struck with the disease; no Aricept for me.
aj
